Patent application number | Description | Published |
20130316994 | Methods of Reducing Risk of Hepatobiliary Dysfunction During Rapid Weight Loss with METAP-2 Inhibitors - The invention generally relates in part to methods of reducing hepatobiliary dysfunction and reducing risk of incident hepatobiliary dysfunction, comprising administering a MetAP2 inhibitor to patients in need thereof. The invention also relates in part to methods of effecting weight loss while reducing hepatic injury or risk thereof, comprising administering a MetAP2 inhibitor. | 11-28-2013 |
20140011870 | Methods of Treating Obesity Using an Effective Dose of a METAP-2 Inhibitor - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using effective of amounts of a MetAP-2 inhibitor. | 01-09-2014 |
20140045934 | Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g., a MetAP-2 inhibitor. | 02-13-2014 |
20140045935 | Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a MetAP-2 inhibitor. | 02-13-2014 |
20140051752 | Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a MetAP-2 inhibitor. | 02-20-2014 |
20140073691 | Methods and composition for Treating Thyroid Hormone Related Disorders - The invention generally relates to methods of improving thyroid hormone sensitivity or treating a thyroid hormone resistance related disorder in a patient in need thereof, comprising administering a pharmaceutically effective amount of a MetAP-2 inhibitor. Such methods may include administering a MetAP-2 inhibitor at a dose that does not substantially modulate angiogenesis. | 03-13-2014 |
20140336251 | METHODS OF TREATING AGE RELATED DISORDERS - The invention generally relates to methods of treating a patient having, and/or at risk of, oxidative distress disorders and/or age-related disorders. The disclosure also generally relates to methods of treating memory impairment or enhancing the cognitive function of a patient in need thereof. Such methods may include administering a therapeutically effective amount of a MetAP2 inhibitor. | 11-13-2014 |
20150209320 | METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions. In certain embodiments, the invention provides a method of treating an overweight or obese subject including administering a MetAP2 inhibitor in which the amount administered does not substantially modulate angiogenesis. | 07-30-2015 |
20150209321 | TREATMENT OF OBESITY USING NON-DAILY ADMINISTRATION OF 6-O-(4-DIMETHYLAMINOETHOXY) CINNAMOYL FUMAGILLOL - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a MetAP-2 inhibitor. | 07-30-2015 |